Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Opsonins and pattern-recognition components of the mononuclear phagocyte system" refers to a broad functional category of molecules and receptors that mediate the innate immune response within monocytes, macrophages, and dendritic cells (Janeway et al., 2016). Opsonins, including complement proteins like C3b and various immunoglobulins, serve as molecular tags that facilitate the recognition and engulfment of pathogens by phagocytic receptors such as Fc receptors and complement receptors (Abbas et al., 2021). Pattern-recognition receptors (PRRs), such as Toll-like receptors (TLRs), NOD-like receptors (NLRs), and C-type lectin receptors (CLRs), are specialized to detect conserved microbial motifs known as pathogen-associated molecular patterns (PAMPs) (Medzhitov, 2007). This system is essential for host defense, the initiation of inflammation, and the clearance of apoptotic cells to maintain tissue homeostasis. Dysregulation of these components is a hallmark of sepsis, chronic inflammatory diseases, and autoimmune conditions (Ricklin et al., 2010). While the system as a whole is not a single drug target, specific components are targeted by therapeutic agents; for example, eculizumab inhibits the complement protein C5, and imiquimod acts as an agonist for TLR7 to treat various conditions (StatPearls, 2023).
Modulation of innate immune recognition, enhancement or inhibition of phagocytosis, and regulation of inflammatory signaling pathways.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Opsonins and pattern-recognition components of the mononuclear phagocyte system.